S&P 500 climbs, but Nvidia slip keeps lid on gains
Investing.com -- French pharmaceutical giant Sanofi’s Paris headquarters was searched on Tuesday as part of a tax fraud investigation, according to Le Monde.
Approximately 30 judicial tax officers from the National Anti-Fraud Office (ONAF), two magistrates from the National Financial Prosecutor’s Office (PNF), and three specialized assistants conducted the search at the company’s headquarters.
According to information confirmed by the PNF, Sanofi is at the center of a preliminary investigation that began in January 2024. The investigation involves allegations of "money laundering of tax fraud," "money laundering of aggravated or organized tax fraud," and "criminal conspiracy."
When contacted about the search, Sanofi stated that it had "like many other companies, used a financing arrangement proposed by Société Générale as part of an acquisition operation carried out more than ten years ago." This arrangement is now being investigated by the National Financial Prosecutor’s Office.
The pharmaceutical company maintains that it "complied with all applicable laws and regulations in this case" and said it "reserves all its rights and will cooperate with the authorities."
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.